Evidence map›Paper›PMID 34303065›Full record

ArticleBioelectrochemistry (Amsterdam, Netherlands)2021

Generation of Tumor-activated T cells Using Electroporation.

Nastaran Alinezhadbalalami, Philip M Graybill, Khan Mohammad Imran, Scott S Verbridge, Irving C Allen, Rafael V Davalos

Abstract read
In one paragraph

Article in Bioelectrochemistry (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Magic bubbles: utilizing histotripsy to modulate the tumor microenvironment and improve systemic anti-tumor immune responses.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2023
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nastaran AlinezhadbalalamiDepartment of Biomedical Engineering and Mechanics, Virginia Tech, 325 Stanger Street, Blacksburg, VA 24061, USA; Institute for Critical Technology and Applied Sciences, Virginia Tech, Kelly Hall, Blacksburg, VA 24061, USA. Electronic address: nalinezh@vt.edu.
Philip M GraybillDepartment of Mechanical Engineering, Virginia Tech, Goodwin Hall, 635 Prices Fork Road, Blacksburg, VA 24061, USA; Institute for Critical Technology and Applied Sciences, Virginia Tech, Kelly Hall, Blacksburg, VA 24061, USA. Electronic address: pmg1@vt.edu.
Khan Mohammad ImranGraduate Program in Translational Biology, Medicine and Health, Virginia Tech, 1 Riverside Circle, Roanoke, VA 24016, USA; Institute for Critical Technology and Applied Sciences, Virginia Tech, Kelly Hall, Blacksburg, VA 24061, USA. Electronic address: imrankhan@vt.edu.
Scott S VerbridgeDepartment of Biomedical Engineering and Mechanics, Virginia Tech, 325 Stanger Street, Blacksburg, VA 24061, USA; Institute for Critical Technology and Applied Sciences, Virginia Tech, Kelly Hall, Blacksburg, VA 24061, USA. Electronic address: sverb@vt.edu.
Irving C AllenDepartment of Biomedical Sciences and Pathobiology, Virginia Tech, 205 Duck Pond Drive, Blacksburg, VA 24061, USA; Institute for Critical Technology and Applied Sciences, Virginia Tech, Kelly Hall, Blacksburg, VA 24061, USA. Electronic address: icallen@vt.edu.
Rafael V DavalosDepartment of Biomedical Engineering and Mechanics, Virginia Tech, 325 Stanger Street, Blacksburg, VA 24061, USA; Department of Mechanical Engineering, Virginia Tech, Goodwin Hall, 635 Prices Fork Road, Blacksburg, VA 24061, USA; Institute for Critical Technology and Applied Sciences, Virginia Tech, Kelly Hall, Blacksburg, VA 24061, USA. Electronic address: davalos@vt.edu.

Funding

High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatmentR01CA213423 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI DAVALOS, RAFAEL VIDAL, VERBRIDGE, SCOTT S · 2017 to 2021
$1.7M
Employing Novel Porcine Models of Orthotopic Pancreatic Cancer to Evaluate Histotripsy Based Tumor Ablation StrategiesR21EB028429 · NIBIB · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI ALLEN, IRVING C · 2019 to 2020
$428k
Development of an improved vaccine against Brucella abortusR03AI151494 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI CASWELL, CLAYTON C · 2020 to 2021
$156k
NCI NIH HHS R01 CA213423NIAID NIH HHS R03 AI151494NIBIB NIH HHS R21 EB028429
6 · The paper itself

Abstract

Expansion of cytotoxic T lymphocytes (CTLs) is a crucial step in almost all cancer immunotherapeutic methods. Current techniques for expansion of tumor-reactive CTLs present major limitations. This study introduces a novel method to effectively produce and expand tumor-activated CTLs using high-voltage pulsed electric fields. We hypothesize that utilizing high-voltage pulsed electric fields may be an ideal method to activate and expand CTLs due to their non-thermal celldeath mechanism. Tumor cells were subjected to high-frequency irreversible electroporation (HFIRE) with various electric field magnitudes (1250, 2500 V/cm) and pulse widths (1, 5, and 10 µs), or irreversible electroporation (IRE) at 1250 V/cm. The treated tumor cells were subsequently cocultured with CD4+ and CD8+ T cells along with antigen-presenting cells. We show that tumor-activated CTLs can be produced and expanded when exposed to treated tumor cells. Our results suggest that CTLs are more effectively expanded when pulsed with HFIRE conditions that induce significant cell death (longer pulse widths and higher voltages). Activated CD8+ T cells demonstrate cytotoxicity to untreated tumor cells suggesting effector function of the activated CTLs. The activated CTLs produced with our technique could be used for clinical applications with the goal of targeting and eliminating the tumor.

Indexed as

Cell Line, TumorElectroporationGlioblastomaHumansT-Lymphocytes, CytotoxicAntigen presentationAnti-tumor immunityCytotoxic T cellHigh frequency irreversible electroporationIrreversible electroporationT cell Activation

Identifiers

PMID34303065
PMCPMC8504467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.